Stefan Kaufmann

Directeur/Membre du Conseil chez Bio Ventures for Global Health

76 ans

Consumer Services

Health Technology

Postes actifs de Stefan Kaufmann

Sociétés	Poste	Début	Fin
Vakzine Projekt Management GmbH Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany.	Corporate Officer/Principal	-	-
Bio Ventures for Global Health	Directeur/Membre du Conseil	-	-

Sociétés	Poste	Début	Fin
Universität Ulm	Corporate Officer/Principal	01/01/1998	01/01/1998

Max-Planck-Institute for Molecular Genetics	Undergraduate Degree
The Johannes Gutenberg University of Mainz	Doctorate Degree

Internationale

Allemagne	5
Etats-Unis	2

Opérationnelle

Corporate Officer/Principal	2
Undergraduate Degree	1
Doctorate Degree	1

Sectorielle

Consumer Services	4
Health Technology	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Entreprise privées	2
Vakzine Projekt Management GmbH Vakzine Projekt Management GmbH Pharmaceuticals: MajorHealth Technology Vakzine Projekt Management GmbH develops vaccines and biopharmaceuticals products from laboratory stages through to clinical examination. It offers VPM2001 vaccine to prevent human cytomegalovirus infections and VPM5001 Soluferon vaccine, treatment for multiple sclerosis (MS) and hepatitis C. The company was founded in August 2002 and is headquartered in Hannover, Germany.	Health Technology
Bio Ventures for Global Health

Entreprise privées

Health Technology

Bio Ventures for Global Health